There is a longstanding and recently rejuvenated enthusiasm for biomarkers that precisely
and specifically reflect the pathophysiologic and clinical changes in systemic lupus …

Despite the longstanding interest and large number of publications on biomarkers in lupus,
there are no validated and widely accepted biomarkers of systemic lupus erythematosus to …

The search for lupus biomarkers to diagnose, monitor, stratify, and predict individual
response to therapy is currently more intense than ever before. This effort is essential for …

Few biomarkers for systemic lupus erythematosus (SLE) have been validated and employed
for making clinical decisions. The lack of reliable, specific biomarkers for SLE hampers the …

Introduction Systemic lupus erythematosus (SLE) is complex autoimmune disease with
heterogenous manifestations, unpredictable disease course and response to treatment. One …

Systemic lupus erythematosus (SLE) is the most heterogeneous chronic autoimmune
disease. Biologic markers that reliably describe various aspects of SLE could be used to …

The urgent need for lupus biomarkers was demonstrated in September 2011 during a
Workshop sponsored by the Food and Drug Administration: Potential Biomarkers Predictive …

Although considered a prototypic autoimmune disease, the hallmark of systemic lupus
erythematosus (SLE) is its heterogeneity. Accordingly, manifestations can vary widely from …

There is a high level of interest in the identification and validation of biomarkers that
precisely reflect specific aspects of systemic lupus erythematosus (SLE). Patients are hoping …

During the last decades, there has been an increased interest in the discovery and
validation of biomarkers that reliably reflect specific aspects of lupus. Although many …